Related Experiment Videos
Multifactorial determinants of reduced coronary flow reserve after dipyridamole in dilated cardiomyopathy
Insights
Patients with dilated cardiomyopathy have impaired coronary flow reserve. Dipyridamole testing revealed significantly reduced coronary sinus blood flow and increased coronary resistance in these patients, indicating a restricted coronary flow reserve not explained by pressure changes.
Area of Science:
- Cardiology
- Cardiovascular Physiology
Background:
- Dilated cardiomyopathy (DC) is a severe heart condition affecting left ventricular function.
- Assessing coronary flow reserve is crucial for understanding myocardial health in DC patients.
Purpose of the Study:
- To investigate coronary sinus blood flow and coronary resistance in patients with severe dilated cardiomyopathy compared to controls.
- To evaluate the coronary flow reserve response to dipyridamole in DC patients.
Main Methods:
- Coronary sinus blood flow and coronary resistance were measured in 7 control patients and 11 DC patients.
- Dipyridamole was administered intravenously to assess coronary flow reserve.
- Correlations between blood flow and various pressure measurements were analyzed.
Main Results:
- Basal coronary sinus blood flow was similar between groups.
- Dipyridamole significantly reduced coronary sinus blood flow and its ratio to basal flow in DC patients (p < 0.001).
- Coronary resistance was significantly higher in DC patients post-dipyridamole (p < 0.01).
Conclusions:
- Patients with severe dilated cardiomyopathy exhibit a significantly restricted coronary flow reserve.
- This restriction is not fully explained by elevated left ventricular diastolic pressure or reduced coronary perfusion pressure.
- Further investigation is needed to elucidate the mechanisms behind impaired coronary vasodilation in DC.
Abstract:
Coronary sinus blood flow (ml/100 g left ventricular [LV] mass/min) and coronary resistance (mean aortic minus LV mean diastolic pressures/coronary sinus blood flow, mm Hg/[ml/100 g/min]) were studied in 7 control patients and in 11 patients with severe dilated cardiomyopathy (DC) and normal coronary arteriograms. Basal coronary sinus blood flow was not different in the 2 groups. After intravenous administration of dipyridamole (0.14 mg/kg/min X 4 min), coronary sinus blood flow and dipyridamole/basal coronary sinus blood flow ratio were significantly (p less than 0.001) lower in the DC group than in the normal group (coronary sinus blood flow 188 +/- 48 vs 408 +/- 58, respectively; blood flow ratio 1.78 +/- 0.35 vs 4.01 +/- 0.56, respectively), and the coronary resistance was higher in the DC group than in the control group (0.39 +/- 0.15 vs 0.22 +/- 0.03, respectively, p less than 0.01). After administration of dipyridamole in patients with DC, no correlation could be found between coronary sinus blood flow and LV mean diastolic, mean aortic or coronary driving pressures, i.e., mean aortic minus LV mean diastolic pressures. Thus, in DC patients, neither an elevated LV diastolic pressure nor a low coronary perfusion pressure can totally account for the restriction of the coronary flow reserve after dipyridamole.